Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee ...

The "Regenerative Medicine Collaboration and Licensing Deals 2019-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of 1390 regenerative medicine ...

The latest announcement is out from Immix Biopharma ( (IMMX) ).

The Wyss Institute is proud to welcome three new Associate Faculty members: Ahmad (Mo) Khalil, Ph.D., Jarad Mason, Ph.D., and Chao-ting (Ting) Wu, Ph.D. Each has a history of collaborating with the ...

Osteopore Ltd. ( ($AU:OSX) ) has provided an announcement. Osteopore Limited has announced a further drawdown of its Tranche 1 redeemable ...

Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells.

The nanopharmaceuticals market presents opportunities in addressing chronic diseases through enhanced targeted therapies and ...

Mr Alfred Lim, CEO of EUDA, commented, “Integrating blockchain utility into our healthcare ecosystem allows us to bridge health engagement with real-world value. This initiative marks an important ...

IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an investment partnership with the Centre for Commercialization of Regenerative ...

Orthopedic regenerative medicine evolves with multicenter efforts to customize orthobiologic treatments and improve patient outcomes by 2026.

Regenerative medicine has emerged as one of the most dynamic fields of modern biomedical research, and stem cells continue to ...

Stem cells play a central role in regenerative medicine, since they possess the capacity for self renewal and the ability to ...